The addition is expected to accelerate Labcorp’s liquid biopsy capabilities and expand its oncology portfolio of next-generation sequencing-based genomic profiling capabilities, the company said February 21.
The acquisition was announced Dec. 23.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.